Are both aspirin and heparin justified as adjuncts to thrombolytic therapy for acute myocardial infarction?

Lancet. 1993 Jun 19;341(8860):1574-7. doi: 10.1016/0140-6736(93)90707-n.
No abstract available

Publication types

  • Review

MeSH terms

  • Aspirin / administration & dosage
  • Aspirin / therapeutic use*
  • Chemotherapy, Adjuvant
  • Heparin / administration & dosage
  • Heparin / therapeutic use*
  • Humans
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / mortality
  • Thrombolytic Therapy*

Substances

  • Heparin
  • Aspirin